Skip to content

Development and Validation of a NIRS-based Sinusitis Screening

Development and Validation of a NIRS-based Sinusitis Screening

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01485484
Enrollment
161
Registered
2011-12-05
Start date
2011-07-28
Completion date
2015-07-07
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinusitis

Brief summary

The research at University of California Irvine, Beckman laser institute and Praxis Biosciences Incorporation, develope near-infrared trans-illumination methods. The optical imaging tool that can determine acute sinusitis and the response to treatment therapy.

Detailed description

In the United States, approximately one in seven people develop sinusitis each year, and 20 million cases of acute bacterial sinusitis become chronic to require medical treatment. The optic light from the illumination wand travelled through the pallet into the sinuses and exited the face. The optic device can determine air-filled and fluid/tissue-filled spaces in the sinus cavity during clinical exam.

Interventions

DEVICEOptic imaging use near-infrared trans-illumination methods

Optic imaging use near-infrared trans-illumination methods

Sponsors

Beckman Laser Institute University of California Irvine
CollaboratorOTHER
University of California, Irvine
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female 18 years of age and older * Subject with normal sinus * Subject who has been diagnosed and confirm by their physician

Exclusion criteria

* Younger than 18 years old * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Sinus Healthup to 4 weeksAssessment of sinusitis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026